✦ LIBER ✦
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer
✍ Scribed by Chen, Xiaosong; Ye, Guolin; Zhang, Chenfang; Li, Xinzheng; Chen, Yiding; Xie, Xiaohong; Zheng, Hong; Cao, Yali; Wu, Kejin; Ni, Duo; Tang, Jinhai; Wei, Ziguo; Shen, Kunwei
- Book ID
- 121593610
- Publisher
- Springer US
- Year
- 2013
- Tongue
- English
- Weight
- 439 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.